Left Atrial Appendage Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: Prevalence and Risk Factors
Journal of the American Heart Association · 03.02.2026 · 15 (3)
DOI: 10.1161/jaha.125.042010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.02.2026. Verfasst von Leon Dinshaw und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart and Vascular Center Hamburg University Medical Center Hamburg-Eppendorf Hamburg Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Cardiomyopathy, Hypertrophic, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM) and increases stroke risk, primarily due to thromboembolism from the left atrial appendage (LAA). Oral anticoagulation (OAC) is recommended, but data on LAA thrombus (LAAT) in HCM and AF are limited. The current study aimed to assess LAAT prevalence in patients with HCM and AF.
Methods
We retrospectively analyzed 170 patients with HCM and AF (mean age, 67.7±12.4 years; 57.1% men) who underwent at least one transesophageal echocardiogram (TEE) during a median follow‐up of 41.5 months (interquartile range, 15–77 months).
Results
At the time of TEE, 147 (86.5%) patients were undergoing OAC, with 52 (30.6%) taking vitamin K antagonists and 95 (55.9%) taking non–vitamin K antagonist oral anticoagulants. LAAT was found in 36 patients (21.2%), with prevalence rates of 23.1% (n=12) in vitamin K antagonist users, 16.8% (n=16) in non–vitamin K antagonist oral anticoagulant users, and 34.8% (n=8) in those without OAC. Non–vitamin K antagonist oral anticoagulant use was associated with a significant LAAT risk reduction compared with no OAC (odds ratio, 0.20 [95% CI, 0.05–0.73]; P =0.02). Decreased LAA flow velocity ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Heart and Vascular Center Hamburg University Medical Center Hamburg-Eppendorf Hamburg Germany.
- Department of Cardiology Sana Hanse Hospital Wismar Wismar Germany.
- Department of Cardiology, Albertinen Heart and Vascular Center Albertinen Hospital Hamburg Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck Germany.
- Institute of Cardiovascular Sciences University of Birmingham UK.
ORCID-Profile: Leon Dinshaw, Benjamin Lippmann, Ruben Schleberger, Laura Rottner, Jannis Dickow, Marc D Lemoine, Feifan Ouyang, Paulus Kirchhof, Monica Patten, Andreas Rillig
Zitieren
APA
Dinshaw, L., Lippmann, B., Schleberger, R., Rottner, L., Moser, F., Dickow, J., Münkler, P., Lemoine, M. D., Schneider, H., Reißmann, B., Ouyang, F., Metzner, A., Kirchhof, P., Patten, M., & Rillig, A. (2026). Left Atrial Appendage Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: Prevalence and Risk Factors. Journal of the American Heart Association, 15(3). https://doi.org/10.1161/jaha.125.042010
Vancouver
Dinshaw L, Lippmann B, Schleberger R, Rottner L, Moser F, Dickow J, et al. Left Atrial Appendage Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: Prevalence and Risk Factors. Journal of the American Heart Association. 2026;15(3). doi:10.1161/jaha.125.042010
BibTeX
@article{Dinshaw2026,
author = {Dinshaw, Leon and Lippmann, Benjamin and Schleberger, Ruben and Rottner, Laura and Moser, Fabian and Dickow, Jannis and Münkler, Paula and Lemoine, Marc D and Schneider, Henrik and Reißmann, Bruno and Ouyang, Feifan and Metzner, Andreas and Kirchhof, Paulus and Patten, Monica and Rillig, Andreas},
title = {Left Atrial Appendage Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: Prevalence and Risk Factors},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {3},
doi = {10.1161/jaha.125.042010}
}
EUVIMED